Masahito Shibano
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical impact of opioid use in patients with urothelial carcinoma treated with pembrolizumab: a single center retrospective study.
Journal: Immunotherapy
Published: July 15, 2026
Effect of Vonoprazan, potassium-competitive acid blocker, on Atezolizumab plus Bevacizumab efficacy in patients with hepatocellular carcinoma: a multicenter retrospective study.
Journal: International journal of clinical oncology
Published: August 06, 2025
Potassium-competitive acid blocker has more negative impacts on clinical outcomes in patients with non-small cell lung cancer treated with checkpoint inhibitors than those of proton pump inhibitors.
Journal: International journal of clinical oncology
Published: February 03, 2025
A multicenter retrospective study evaluating the effect of proton pump inhibitors on adjuvant tegafur-uracil/leucovorin efficacy for stage II-III colorectal cancer.
Journal: Scientific reports
Published: October 17, 2024
Clinical impact of concomitant BIO-three use in advanced or recurrent non-small cell lung cancer treated with immune-checkpoint inhibitor.
Journal: International journal of clinical oncology
Published: April 30, 2024
Effects of semi-solidification of enteral nutrients on the pharmacokinetic behavior of orally administered carbamazepine in rats.
Journal: International journal of medical sciences
Published: April 04, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026